Kidney cancer scan study pulled before it even started
NCT ID NCT07084909
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aimed to see if a special PET/CT scan using a radioactive tracer called piflufolastat F 18 could better detect whether clear cell renal cell carcinoma (a type of kidney cancer) has spread. Researchers planned to enroll adults with suspected or high-risk metastatic disease. However, the study was withdrawn before any participants were enrolled, so no data was collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
piflufolastat F 18 (a radioactive tracer used in PET/CT scans)
What this could lead to
If successful, this imaging method could help doctors more accurately detect if kidney cancer has spread, guiding better treatment decisions.
What could go wrong
The study was withdrawn before any participants enrolled, so no results are available. It is unclear if the approach would work as hoped.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLEAR CELL RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University in St. Louis
St Louis, Missouri, 63130, United States
-
XCancer
Omaha, Nebraska, 68130, United States